Company Filing History:
1 out of 73 
1 out of 339 
Years Active: 2008
Title: **Masahiko Aoki: Pioneering Innovations in Cancer Treatment**
Introduction
Masahiko Aoki is a notable inventor based in Tokyo, Japan, whose groundbreaking work has the potential to revolutionize cancer treatment. With a unique focus on monoclonal antibodies, Aoki has developed innovations that specifically target various cancer types, including non-small cell lung cancer, pancreatic cancer, and gastric cancer.
Latest Patents
Aoki holds a patent for a novel human monoclonal antibody and related technologies, which encompass a hybridoma, a pharmaceutical composition, and a diagnostic reagent. The invention involves producing a distinctive antibody that recognizes cancer cells, formulated through the fusion of lymphocytes derived from a cancer tissue of a patient with mouse myeloma cells. This innovative approach enables the creation of anti-cancer drugs by utilizing the antibody alone or by anchoring it on the surface of a liposome that contains either a toxin or an encapsulated anti-cancer drug. The detailed patent outlines the specific amino acid sequences (SEQ ID NO: 115 and SEQ ID NO: 117) crucial for the variable regions of the antibody's heavy and light chains.
Career Highlights
Throughout his career, Masahiko Aoki has made notable contributions to the field of pharmaceutical sciences. He has worked with renowned organizations, including Mitsubishi Pharma Corporation and Keio University, where he has honed his skills and expertise in the development of therapeutic solutions.
Collaborations
Aoki's innovative journey has been enriched through collaborations with esteemed colleagues, including Saiko Hosokawa and Yoko Hirakawa. These partnerships have fostered a collaborative environment conducive to groundbreaking research and development in the field of oncology.
Conclusion
Masahiko Aoki's dedication to advancing cancer treatment through innovative monoclonal antibodies exemplifies the impact of inventors in the medical field. His patented technologies not only contribute to new anti-cancer strategies but also inspire future research endeavors aimed at improving patient outcomes in oncology. The legacy of Masahiko Aoki serves as a testament to the vital role that inventors play in transforming healthcare.